These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34447677)
1. Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Han D; Chen J; Liu S; Zhang Z; Zhao Z; Jin W; Xin Y J Clin Transl Hepatol; 2021 Aug; 9(4):484-493. PubMed ID: 34447677 [TBL] [Abstract][Full Text] [Related]
2. Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease. Liu S; Xiao J; Zhao Z; Wang M; Wang Y; Xin Y J Clin Transl Hepatol; 2021 Feb; 9(1):3-14. PubMed ID: 33604250 [TBL] [Abstract][Full Text] [Related]
3. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Makri E; Orfanidou M; Makri ES; Goulas A; Terpos E; Polyzos SA J Clin Exp Hepatol; 2024; 14(3):101353. PubMed ID: 38435724 [TBL] [Abstract][Full Text] [Related]
4. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis. Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393 [TBL] [Abstract][Full Text] [Related]
5. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis. Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351 [TBL] [Abstract][Full Text] [Related]
6. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Polyzos SA; Toulis KA; Goulis DG; Zavos C; Kountouras J Metabolism; 2011 Mar; 60(3):313-26. PubMed ID: 21040935 [TBL] [Abstract][Full Text] [Related]
7. Serum Resistin Level and Its Receptor Gene Expression in Liver Biopsy as Predictors for the Severity of Nonalcoholic Fatty Liver Disease. Hegazy M; Abo-Elfadl S; Mostafa A; Ibrahim M; Rashed L; Salman A Euroasian J Hepatogastroenterol; 2014; 4(2):59-62. PubMed ID: 29699348 [TBL] [Abstract][Full Text] [Related]
9. Maternal serum level of resistin is associated with risk for gestational diabetes mellitus: A meta-analysis. Hu SM; Chen MS; Tan HZ World J Clin Cases; 2019 Mar; 7(5):585-599. PubMed ID: 30863758 [TBL] [Abstract][Full Text] [Related]
10. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Zhou Z; Chen H; Ju H; Sun M Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435 [TBL] [Abstract][Full Text] [Related]
11. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis. Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181 [TBL] [Abstract][Full Text] [Related]
12. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Singh S; Allen AM; Wang Z; Prokop LJ; Murad MH; Loomba R Clin Gastroenterol Hepatol; 2015 Apr; 13(4):643-54.e1-9; quiz e39-40. PubMed ID: 24768810 [TBL] [Abstract][Full Text] [Related]
13. Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nikoli A; Orfanidou M; Goulas A; Goulis DG; Polyzos SA J Gastroenterol Hepatol; 2024 Dec; 39(12):2572-2581. PubMed ID: 39417560 [TBL] [Abstract][Full Text] [Related]
14. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. Senateş E; Colak Y; Yeşil A; Coşkunpinar E; Sahin O; Kahraman OT; Erkalma Şenateş B; Tuncer I Minerva Med; 2012 Oct; 103(5):369-76. PubMed ID: 23042372 [TBL] [Abstract][Full Text] [Related]
15. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis. Makri ES; Evripidou K; Polyzos SA J Gastroenterol Hepatol; 2024 May; 39(5):806-817. PubMed ID: 38238084 [TBL] [Abstract][Full Text] [Related]
16. Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease. Polyzos SA; Kountouras J; Polymerou V; Papadimitriou KG; Zavos C; Katsinelos P Ann Hepatol; 2016; 15(5):705-14. PubMed ID: 27493109 [TBL] [Abstract][Full Text] [Related]
17. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease. Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y Int J Clin Exp Med; 2014; 7(11):4191-8. PubMed ID: 25550930 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis. Yao Y; Miao X; Zhu D; Li D; Zhang Y; Song C; Liu K Endocrine; 2019 Aug; 65(2):227-237. PubMed ID: 31243652 [TBL] [Abstract][Full Text] [Related]
19. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911 [TBL] [Abstract][Full Text] [Related]
20. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus. Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]